Login to Your Account



Newly Identified Enzyme Could Rival PARPs as a Drug Target

By Sharon Kingman
Staff Writer

Wednesday, March 13, 2013
LONDON – Study of a family affected by an inherited neurological disease has helped to reveal the identity of an enzyme that could point the way to new therapies for cancer and cardiovascular disease.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription